Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1590-3478
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence ; day:10 ; month:5 ; year:2022 ; pages:1-8
Neurological sciences ; (10.5.2022), 1-8
- Urheber
-
Liguori, Claudio
Fernandes, Mariana
Cerroni, Rocco
Ludovisi, Raffaella
Mercuri, Nicola Biagio
Stefani, Alessandro
Pierantozzi, Mariangela
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-022-06111-x
- URN
-
urn:nbn:de:101:1-2022071621460142478200
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liguori, Claudio
- Fernandes, Mariana
- Cerroni, Rocco
- Ludovisi, Raffaella
- Mercuri, Nicola Biagio
- Stefani, Alessandro
- Pierantozzi, Mariangela
- SpringerLink (Online service)
Ähnliche Objekte (12)
Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Neurokinin Concentrations in Cerebrospinal Fluid. A Preliminary Study in Parkinson’s Disease
Camptocormia due to myotinilopathy, Parkinson’s disease, or both? : Camptocormia and axial myopathy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Parkinson’s disease tremor prediction using EEG data analysis-A preliminary and feasibility study
Parkinson
Parkinson
Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Neurokinin Concentrations in Cerebrospinal Fluid. A Preliminary Study in Parkinson’s Disease
Camptocormia due to myotinilopathy, Parkinson’s disease, or both? : Camptocormia and axial myopathy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Parkinson’s disease tremor prediction using EEG data analysis-A preliminary and feasibility study
Parkinson
Parkinson
Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Neurokinin Concentrations in Cerebrospinal Fluid. A Preliminary Study in Parkinson’s Disease
Camptocormia due to myotinilopathy, Parkinson’s disease, or both? : Camptocormia and axial myopathy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Parkinson’s disease tremor prediction using EEG data analysis-A preliminary and feasibility study
Parkinson
Parkinson
Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed